Elif İşleyen Çolak

Dr. Elif İşleyen Çolak

Nuclear Medicine, Bursa Uludağ University Faculty Of Medicine, Bursa, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2026 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
HÖHikmet Öztop
Hikmet Öztop
FHFAZIL CAGRI HUNUTLU
FAZIL CAGRI HUNUTLU
EÇElif İşleyen Çolak
Elif İşleyen Çolak
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
AŞAhmet Bilgehan Bilgehan Şahin
Ahmet Bilgehan Bilgehan Şahin
OGOzen Oz Öz Gul
Ozen Oz Öz Gul
Thyroid incidentalomas (TIs) detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) are associated with an increased risk of malignancy, particularly in the presence of focal FDG uptake. While quantitative PET/CT parameters, such as the maximum standardized uptake value (SUVmax), have been extensively studied, current management guidelines primarily rely on nodule size and ultrasonographic features. This study aimed to evaluate whether PET/CT-derived radiological parameters provide additional information for malignancy in FDG-avid TIs. This retrospective single-center study included patients with focal FDG-avid thyroid incidentalomas detected on PET/CT who underwent ultrasonographic evaluation and cytological and/or histopathological confirmation. Demographic characteristics, metabolic parameters derived from PET/CT scans, ultrasonographic findings and anatomical localization were documented. Benign and malignant lesions were compared. Receiver operating characteristic (ROC) analysis was conducted to determine the optimal SUVmax cut-off value and logistic regression analyses were employed to identify variables independently associated with malignancy. A total of 53 patients were included, with 13 (24.5%) having malignant thyroid lesions. Malignant nodules demonstrated significantly higher SUVmax values than benign nodules (p=0.008). ROC analysis established a SUVmax cut-off value of 5.8 for discrimination between benign and malignant nodules (AUC: 0.748). Isthmus localization also remained significant in multivariate analysis (p=0.037). No other morphologic or ultrasonographic parameters were significant. In cases of focal FDG-avid TIs, an SUVmax value of ≥5.8 is associated with an increased risk of malignancy and may provide complementary information in risk stratification. However, SUVmax should be interpreted alongside clinical and ultrasonographic findings, not as a standalone decision-making tool.

28 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
EÇElif İşleyen Çolak
Elif İşleyen Çolak
IKIrem Koroglu
Irem Koroglu
DYDegercan Yesilyurt
Degercan Yesilyurt
KKKadircan Karatoprak
Kadircan Karatoprak
EAEray Alper
Eray Alper
Background/Objectives: Parathyroid imaging is used for preoperative localization rather than biochemical diagnosis. Conventional planar and SPECT-based scintigraphy may yield equivocal reports when thyroid activity obscures lesion localization. This study evaluated whether combining software-assisted subtraction imaging with ultrasound-correlated interpretation improves reporting certainty and reduces ambiguity. Methods: This prospective reporting study included 96 consecutive patients referred for parathyroid scintigraphy because of biochemical or clinical suspicion of primary hyperparathyroidism. Each anonymized imaging dataset was evaluated by two independent consensus reader pairs using different interpretation strategies. The control arm (CTRL) used conventional dual-time-point Tc-99m sestamibi planar and SPECT images with Tc-99m pertechnetate thyroid images. The intervention arm (INT) additionally used software-assisted subtraction images and ultrasound-correlated interpretation. Endpoints included suspected parathyroid adenoma (PTA)-positive reporting, certainty, clinically actionable localization, high-confidence localization, and non-actionable reporting. Surgical/pathological reference localization was available in 22 operated patients. Results: INT increased PTA-positive reporting compared with CTRL [82/96 (85.4%) vs. 53/96 (55.2%), p < 0.001]. Median certainty increased from 1 (IQR, 0–2) to 3 (IQR, 1–3) (p < 0.001). Clinically actionable localization increased from 32/96 (33.3%) to 68/96 (70.8%) (p < 0.001), and high-confidence localization increased from 17/96 (17.7%) to 55/96 (57.3%) (p < 0.001). Non-actionable reporting decreased from 64/96 (66.7%) to 28/96 (29.2%). In the operated subgroup, correct localization was higher with INT [20/22 (90.9%) vs. 12/22 (54.5%), p = 0.008]. Conclusions: Software-assisted subtraction imaging, when combined with ultrasound-correlated interpretation, improved the clinical usability of conventional parathyroid scintigraphy by increasing reporting certainty, reducing ambiguity, and improving actionable localization. Reference-based findings were supportive, and ongoing follow-up is expected to provide surgical/pathological confirmation for robust diagnostic accuracy analyses.

7 October 2026 in World Journal of Nuclear Medicine
Verified
Journal Article
Open access
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
CKCagla KARAOGLU
Cagla KARAOGLU
EÇElif İşleyen Çolak
Elif İşleyen Çolak
ECErdem Cubukcu
Erdem Cubukcu
EAEray Alper
Eray Alper
The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in monitoring basal cell carcinoma (BCC) during vismodegib therapy remains poorly defined, particularly in patients with extensive, multifocal, or Gorlin syndrome–associated disease. This study aimed to evaluate metabolic and anatomic treatment-response findings and the incremental diagnostic value of 18F-FDG PET beyond CT in this setting. Patients with histopathologically confirmed BCC who underwent 18F-FDG PET/CT during vismodegib therapy between December 2015 and August 2026 were retrospectively reviewed. Metabolic response was classified using PERCIST (Positron Emission Tomography Response Criteria in Solid Tumors)-like criteria based on serial maximum standardized uptake value (SUVmax) measurements, and tumor-to-liver ratio (TLR) was additionally calculated as a background-normalized metabolic parameter. Patients without suitable paired imaging for metabolic response assessment because of absent follow-up PET/CT, lack of an FDG-avid target lesion, or intervening local treatment were considered not evaluable for categorical metabolic response. Baseline and follow-up SUVmax and TLR values were compared using the Wilcoxon signed-rank test. Continuous variables were summarized using descriptive statistics, and categorical variables were reported as frequencies and percentages. Sixteen patients were included, of whom 5 had Gorlin syndrome. Primary lesions were predominantly craniofacial, occurring in 15 of 16 patients (93.8%), and 11 patients had orbital involvement. Baseline FDG avidity was present in 10 patients, whereas 6 had low or absent uptake. Among 8 patients with paired quantitative PET/CT measurements, the median baseline and follow-up SUVmax values were 5.45 and 4.50, respectively, with no significant interval change (Wilcoxon signed-rank test, p = 1.000). Similarly, paired TLR values showed no significant interval change (p = 0.834). Categorical PET response assessment was feasible in seven patients. Others were not evaluable because of absent follow-up PET/CT, no FDG-avid target lesion, or intervening local treatment. A CT-measurable target lesion was present in nine patients (56.2%), while PET provided incremental information beyond the CT component in three patients (18.8%), primarily through the identification of additional metabolically active lesions or disease findings not apparent on CT. Although 18F-FDG PET/CT may provide additional metabolic information in selected patients with advanced, multifocal, or Gorlin syndrome–associated BCC, its incremental diagnostic contribution beyond CT during vismodegib therapy appears limited. Selective use may therefore be more appropriate than routine serial imaging.

2 September 2026 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
HÖHikmet Öztop
Hikmet Öztop
FHFAZIL CAGRI HUNUTLU
FAZIL CAGRI HUNUTLU
EÇElif İşleyen Çolak
Elif İşleyen Çolak
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
AŞAhmet Bilgehan Bilgehan Şahin
Ahmet Bilgehan Bilgehan Şahin
OGOzen Oz Öz Gul
Ozen Oz Öz Gul
We read with interest the study by Öztürk et al. evaluating the performance of ultrasound risk stratification systems in focal FDG-avid thyroid incidentalomas. While TIRADS-based systems have shown high diagnostic performance, the SUVmax cut-off value and negative predictive value reported in their study closely align with our findings. This suggests that SUVmax offers consistent and complementary metabolic risk information across different centers. We believe that SUVmax and ultrasound-based risk stratification systems should not be seen as competing tools but rather as mutually supportive elements of a comprehensive clinical decision-making strategy.

9 March 2026 in Cerrahpasa Medical Journal
Verified
Journal Article
Open access
PDF file
EÇElif İşleyen Çolak
Elif İşleyen Çolak
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
EAEray Alper
Eray Alper
Infections related to cardiac assist devices pose significant diagnostic challenges, especially in patients with multiple implanted systems. A 45-year-old male was reported with both a left ventricular assist device (LVAD) and an implantable cardioverter defibrillator (ICD) evaluated for persistent driveline discharge despite extended antibiotic therapy. Serial cultures were negative for common LVAD pathogens, whereas Mycobacterium tuberculosis complex positivity in pleural fluid and a progressive purified protein derivative response supported concomitant tuberculosis infection. The scan revealed heterogeneous FDG uptake along the LVAD driveline, consistent with active infection, and homogeneous uptake around the pump, interpreted as sterile inflammation likely due to surgical adhesives. No abnormal uptake was observed around the ICD. These findings enabled accurate localization of the infection and prevented unnecessary device removal. Fluorodeoxyglucose (FDG) PET/CT proved valuable in differentiating infectious and non-infectious processes in coexisting cardiac devices, guiding focused surgical and antimicrobial management. This case underscores the growing clinical utility of FDG PET/CT in delineating complex cardiac device infections and its influence on tailored therapeutic decision-making in patients with mechanical circulatory support. Cite this article: İşleyen Çolak E, Bilgiç S, Alper E. FDG PET/CT in the localization of cardiac device infections: discriminating between left ventricular assist device and implantable cardioverter defibrillator infection. Cerrahpaşa Med J. 2026; 50: 0095. doi: 10.5152/cjm.2026.25095